Nasdaq: Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology Please provide your email address to receive an email when new articles are posted on . This year’s Congress of Clinical Rheumatology-East will celebrate the annual meeting’s 40 th anniversary with ... Healio: Congress of Clinical Rheumatology West to feature expanded programs, ‘heavy hitters’ Please provide your email address to receive an email when new articles are posted on .
The 2025 Congress of Clinical Rheumatology West will feature expanded immunology and young investigator programs ... Title: Phase I/II Trial of AllocetraTM Cell Therapy for Knee Osteoarthritis: Clinical Evidence of Response to Modulation of Inflammation Abstract Publication Number: 684 Poster View I: Wednesday, June ... Nasdaq: Enlivex Therapeutics Ltd. to Present Allocetra™ Data at EULAR 2025 Congress in Barcelona Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company based in Ness-Ziona, Israel, announced it will present data on Allocetra™, its proprietary macrophage reprogramming cell therapy for ...
